InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Albanna Amro A., Chairman & CEO. Officer active across 1 companies, notably Aditx Therapeutics, Inc.. Cumulatively, 4 reports have been published. Total volume traded: €2k. The latest transaction was disclosed on 4 June 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
075,000 shares0
Common Stock
SEC:0001213900-21-031448·
075,000 shares0
Common Stock
SEC:0001213900-21-031448:0·
€1,199500 shares@ €2.3981100.0% of flow
Common Stock
SEC:0001213900-21-030431·
Ideal exit: 26 Feb 2022 (T+270)
€1,199500 shares@ €2.398156.64% mcap50.0% of flow
Common Stock
SEC:0001213900-21-030431:0·
Ideal exit: 26 Feb 2022 (T+270)
4 of 4 declarations
About Albanna Amro A.
Amro A. Albanna is the Chairman and CEO of Aditx Therapeutics, Inc. He leads the company by defining the strategic vision and overseeing all operations. His role includes managing human resources, business development, and communication with shareholders. Through his leadership, he ensures that the company remains competitive in the market and meets the needs of its clients while achieving its financial objectives.
